RetaNord sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use and have not been evaluated by the European Medicines Agency or any other regulatory authority.

Combination research blend
KLOW is a four-part research blend — GHK-Cu, BPC-157, TB-500 and KPV — combined in a single vial. It extends the GLOW concept with the addition of KPV, a tripeptide studied in inflammation research.
Both kit sizes ship within the EU — free shipping either way.
Same vial, sold singly out of a small counted stock. The kit is cheaper per vial and ships free.
Plain, unbranded packaging. No product names, no logos — nothing on the outside indicating what is inside. Tracked to a DPD Locker or your address.
Guaranteed delivery. If your order doesn't reach you, we ship it again free — lost, damaged or stolen.
For laboratory and in vitro research use only. Not for human or veterinary use, and not for use in diagnostic procedures.
KLOW builds on the three-peptide GLOW blend by adding KPV, the C-terminal tripeptide of α-MSH studied in inflammation research. All four peptides are presented together in one lyophilized vial; the 80 mg figure is the combined peptide mass per vial.
RetaNord supplies KLOW as fixed kits of 10 or 30 lyophilized vials, each verified at 99%+ identity purity by independent third-party HPLC (Janoshik), and every kit ships with a lot-specific Certificate of Analysis. Supplied for laboratory and in vitro research use only.
KLOW is the three-peptide GLOW blend plus a fourth: KPV, the C-terminal tripeptide of α-melanocyte-stimulating hormone, which published work associates with anti-inflammatory activity.
The other three work as they do in GLOW — GHK-Cu as a copper carrier and gene-expression modulator, BPC-157 in angiogenic and growth-factor signalling, TB-500 in actin regulation and cell migration. Adding KPV brings an inflammation-signalling component to the same vial. As with GLOW, the published research covers the peptides individually.
Mechanistic summary drawn from published literature, provided for research context only. Not a therapeutic claim.
Each of the four has its own literature: GHK-Cu in skin regeneration, BPC-157 in wound healing, thymosin β4 in actin regulation, and KPV in α-MSH anti-inflammatory work.
There is no published trial of the four-peptide combination as such. All four are preclinical research compounds, not approved medicines.
An educational summary of published literature. It is not a claim about any outcome for any buyer, and RetaNord supplies this compound for laboratory research use only.
Sealed, lyophilized vials. 2–8 °C for routine storage; −20 °C or below for long-term. Room temperature is for transit and handling only — it is not a storage state for a peptide.
Once reconstituted. Keep at 2–8 °C and never freeze — ice crystals cause irreversible damage. Reconstituted with bacteriostatic water (0.9% benzyl alcohol) a vial is commonly used within about 30 days; with plain sterile water, within 24–48 hours.
Keep vials sealed and protected from light, and minimise freeze–thaw cycles of frozen stock — each cycle costs potency.
Work out concentration and draw volume in the reconstitution calculator →
| Category | Skin & Recovery |
|---|---|
| Compound class | Research blend — GHK-Cu + BPC-157 + TB-500 + KPV |
| Presentation | 10 vials per kit · lyophilized |
| Available sizes | 80 mg per vial |
| Constituent peptides | GHK-Cu + BPC-157 + TB-500 + KPV · combined peptide mass per vial |
| Physical form | Sterile-filtered, freeze-dried |
| Identity purity | 99%+ (HPLC) |
| Independent testing | Janoshik · third-party HPLC |
| Storage | 2–8°C; −20°C long term |
| Documentation | Lot-specific Certificate of Analysis |
Certificate of Analysis — batch VT724552Independent third-party testing by Janoshik · HPLC purity 99.532% and content verified.View the full report →Selected peer-reviewed literature via PubMed, provided for educational context. A reference does not imply a clinical claim for RetaNord products.
Yes — every kit ships with a lot-specific third-party Certificate of Analysis: independent HPLC purity and content testing by Janoshik, with the batch matching your vials. View the current CoA.
KLOW is GLOW plus KPV — a four-peptide blend rather than three. Both are supplied as 10-vial research kits for laboratory use only.
These research compounds are supplied in fixed kits of 10 identical vials — the standard research quantity. One kit (10 vials) is the minimum order to the EU.
Sealed lyophilized vials keep at 2–8 °C, or −20 °C for long-term storage. Once reconstituted, keep refrigerated and never freeze it. See storage & handling for the full detail.
The volume of bacteriostatic water you add sets the concentration — the vial size alone does not. Enter your vial size and diluent volume in the reconstitution calculator to calculate the concentration for your assay.
Just the individual peptides. Each of the four has its own published literature; there is no published trial of the four-peptide combination as a single entity. The references below are for the constituents.
Every RetaNord kit ships within 24–48 hours, discreetly packaged and tracked. All kits ship within the EU. For laboratory research use only.
Order this kitA person answers every message — the same day, seven days a week.